Key result
MiR-21-3p inhibitor protects against myocardial injury in heart failure models by reducing mitophagy via CPT1A.
Why the study?
Chronic heart failure is linked to inflammation and mitochondrial dysfunction, but the effects of miR-21-3p on macrophage polarization and mitophagy remain to be determined.
Does miR-21-3p inhibition improve myocardial function and reduce excessive mitophagy in preclinical models of chronic heart failure?
Does miR-21-3p inhibition improve myocardial function and reduce excessive mitophagy in preclinical models of chronic heart failure?
Inhibition of miR-21-3p protects against heart failure progression in preclinical models by reducing M1 macrophage polarization and excessive mitophagy via CPT1A upregulation.
MiR-21-3p inhibition merits preclinical follow-up in heart failure; hypothesis-generating from animal data and requires human validation before any clinical consideration.
Chronic heart failure (CHF) is closely associated with inflammation and mitochondrial dysfunction in cardiomyocytes. This study attempts to investigate the effects of microRNA-21-3p (miR-21-3p) on macrophage polarization and mitophagy in CHF. Here we found miR-21-3p was upregulated in CHF and negatively correlated with carnitine palmitoyl transferase 1A (CPT1A). L-palmitoyl carnitine (L-PC) exacerbated isoproterenol (ISO)-induced myocardial structural disruption and fibrosis in rats, which was exacerbated by miR-21-3p. Mechanistically, miR-21-3p accelerated M1 macrophage polarization. Both miR-21-3p inhibitor and CPT1A overexpression suppressed mitophagy. The inhibition of CPT1A on mitophagy was reversed by miR-21-3p. MiR-21-3p targeted CPT1A mRNA and co-localized with CPT1A protein in cardiomyocytes. In the co-culture system of M1 macrophages and H9c2 cells, miR-21-3p mimics in H9c2 cells promoted M1 polarization, whereas miR-21-3p inhibitor reduced M1 phenotype. M1 macrophages exacerbated H9c2 cell damage. These findings support the potential therapeutic targeting of miR-21-3p to regulate inflammation and mitophagy by inducing CPT1A in CHF.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2024) studied Chronic heart failure (n=24). MiR-21-3p inhibitor vs. Negative control inhibitor was evaluated. MiR-21-3p inhibitor protected against myocardial injury by altering macrophage polarization and reducing excessive mitophagy via CPT1A in chronic heart failure models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: